Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Condition: Chronic Hepatitis D Intervention: Drug: Bulevirtide Sponsor: Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDF and Entekavir - Hepatitis B Reactivation
Condition: Hepatitis B Reactivation Intervention: Sponsor: Viral Hepatitis Society Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Condition: Chronic Hepatitis D Intervention: Drug: Bulevirtide Sponsor: Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDF and Entekavir - Hepatitis B Reactivation
Condition: Hepatitis B Reactivation Intervention: Sponsor: Viral Hepatitis Society Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Condition: Chronic Hepatitis D Intervention: Drug: Bulevirtide Sponsor: Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDF and Entekavir - Hepatitis B Reactivation
Condition: Hepatitis B Reactivation Intervention: Sponsor: Viral Hepatitis Society Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Condition: Chronic Hepatitis D Intervention: Drug: Bulevirtide Sponsor: Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDF and Entekavir - Hepatitis B Reactivation
Condition: Hepatitis B Reactivation Intervention: Sponsor: Viral Hepatitis Society Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Condition: Chronic Hepatitis D Intervention: Drug: Bulevirtide Sponsor: Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDF and Entekavir - Hepatitis B Reactivation
Condition: Hepatitis B Reactivation Intervention: Sponsor: Viral Hepatitis Society Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Conditions: Chronic Hepatitis D Interventions: Drug: Bulevirtide Sponsors: Karolinska University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
TDF and Entekavir - Hepatitis B Reactivation
Conditions: Hepatitis B Reactivation Sponsors: Viral Hepatitis Society Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Conditions: Chronic Hepatitis D Interventions: Drug: Bulevirtide Sponsors: Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
HCV Microfluidic Diagnostics
Conditions: Hepatitis C Sponsors: University of Hull; Hull University Teaching Hospitals NHS Trust Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
Condition: Hepatitis B, Chronic Intervention: Other: Exposure factors Sponsors: Qilu Hospital of Shandong University; Linyi People's Hospital; First Affiliated Hospital Xi'an Jiaotong University; First Affiliated Hospital of Wenzhou Medical University; Third Affiliated Hospital, Sun Yat-Sen University; Sir Run Run Shaw Hospital; First Affil iated Hospital of Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
